Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In September 2024, the FTC filed suit against the three major PBM companies CVS Caremark, Express Scripts, and OptumRx along with their affiliated group purchasing organizations, alleging that their practices had artificially inflated insulin prices by favoring high-list-price insulins on formulary to maximize rebate revenue
Nevertheless, further research suggested that a peptide with similar modifications (namely R3) to IGF-1 LR3 may exert increased anabolic potential compared to regular IGF-1 despite the shorter action
The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others
Fox News Digital reached out to GLP-1 manufacturers requesting comment.
US$ 24.72
US$ 23.07
US$ 28.21
US$ 27.79
